Effect of Meal Frequency on Insulin Resistance in Subjects With Type 2 Diabetes
Frequency
2 other identifiers
interventional
54
1 country
1
Brief Summary
Aims and priorities of the project The purpose of this study is to
- 1.test the effect of frequency of meals (six vs. two meals daily with the same daily caloric restriction of -500 kcal/day) on insulin sensitivity, insulin secretion, and hepatic fat content.
- 2.characterize some of the mechanisms of action of different frequencies of meals (amount of visceral fat, hepatic fat content, serum concentrations of adipokines, gut hormones, oxidation stress markers).
- 3.test the ability of the participants to maintain hypocaloric diet on both regimens when educated and left to prepare their meals alone in comparison with those for whom all meals during the study will be provided.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable diabetes-mellitus-type-2
Started Dec 2010
Shorter than P25 for not_applicable diabetes-mellitus-type-2
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2010
CompletedFirst Submitted
Initial submission to the registry
January 6, 2011
CompletedFirst Posted
Study publicly available on registry
January 17, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2011
CompletedApril 6, 2012
April 1, 2012
10 months
January 6, 2011
April 4, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in Insulin Resistance
Insulin Resistance measured by hyperinsulinemic isoglycemic clamp
Insulin resistance will be measured at weeks 0, 12 and 24. Change from baseline to 12 weeks and from week 12 to week 24 will be assessed.
Secondary Outcomes (6)
hepatic fat content
Hepatic fat content will be measured at weeks 0, 12 and 24. Change from baseline to 12 weeks and from week 12 to week 24 will be assessed.
Insulin Secretion
Insulin secretion will be measured at weeks 0, 12 and 24. Change from baseline to 12 weeks and from week 12 to week 24 will be assessed.
insulin sensitivity
Insulin secretion will be measured at weeks 0, 12 and 24.
Fatty acid composition in serum phospholipids
Weeks 0,12 and 24
Gastrointestinal peptides
Weeks 0, 12 and 24
- +1 more secondary outcomes
Study Arms (2)
Arm A: 6 and 2 meals/day
EXPERIMENTAL6 meals/day for the first 12 weeks followed by 2 meals/day for additional 12 weeks at the same caloric restriction (-500 kcal/day)
Arm B: 2 and 6 meals/day
ACTIVE COMPARATOR2 meals/day for the first 12 weeks followed by 6 meals/day for additional 12 weeks at the same caloric restriction (-500 kcal/day)
Interventions
6 meals/day for 12 weeks followed by 2 meals/day for 12 weeks at the same caloric restriction (-500 kcal/day)
2 meals/day for the first 12 weeks followed by 6 meals/day for additional 12 weeks at the same caloric restriction (-500 kcal/day)
Eligibility Criteria
You may qualify if:
- Type 2 diabetes for more than 1 year
- Treatment of T2D. Oral hypoglycemic agents stable for the last 3 months
- HbA1c ≥4.2 and ≤10.5% (IFCC)
- Agek 30-70 years
- Body Mass Index (kg/m2) between 27 and 50
- Willingness to follow both different dietary regimens
- The patient has at least 3 of the symptoms of the metabolic syndrome
You may not qualify if:
- Alcoholism or drug abuse
- Pregnancy, lactation
- Nonstable medication for diabetes, hypertension or dyslipidemia in the last 3 months
- Diagnosis of type 1 diabetes
- Weight loss or weight gain in the last 3 months (\> 5% of the total body weight)
- Cardiostimulant
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Institute for Clinical and Experimental Medicine
Prague, 140 21, Czechia
Related Publications (1)
Kahleova H, Belinova L, Malinska H, Oliyarnyk O, Trnovska J, Skop V, Kazdova L, Dezortova M, Hajek M, Tura A, Hill M, Pelikanova T. Eating two larger meals a day (breakfast and lunch) is more effective than six smaller meals in a reduced-energy regimen for patients with type 2 diabetes: a randomised crossover study. Diabetologia. 2014 Aug;57(8):1552-60. doi: 10.1007/s00125-014-3253-5. Epub 2014 May 18.
PMID: 24838678DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Terezie Pelikanova, Prof., MD
Institute for Clinical and Experimental Medicine
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Dr.
Study Record Dates
First Submitted
January 6, 2011
First Posted
January 17, 2011
Study Start
December 1, 2010
Primary Completion
October 1, 2011
Study Completion
October 1, 2011
Last Updated
April 6, 2012
Record last verified: 2012-04